E-LIB Suche - Ergebnisse für: Woessner, Ralph

1

Comprehensive Assessment of Pharmacokinetics, Pharmacodynam..:

Ji, Yan ; Calonder, Claudio ; Kirsilä, Tiina...
Pharmaceutics. 15 (2023) 9 - p. 2266 , 2023

2

Drug‐Drug Interaction Studies to Evaluate the Effect of Inh..:

Chen, Jin ; Stringer, Rowan ; Shah, Bharti...
Clinical Pharmacology in Drug Development. 11 (2022) 11 - p. 1253-1263 , 2022

Link: https://doi.org/10.1002/..

3

Novel Bruton's tyrosine kinase inhibitor remibrutinib: Asse..:

Schiller, Hilmar ; Huth, Felix ; Schuhler, Carole...
European Journal of Pharmaceutical Sciences. 172 (2022) - p. 106155 , 2022

Link: https://doi.org/10.1016/..

4

Pharmacokinetics of Tropifexor, a Potent Farnesoid X Recept..:

Chen, Jin ; Gu, Jessie ; Shah, Bharti...
The Journal of Clinical Pharmacology. 62 (2022) 4 - p. 520-531 , 2022

Link: https://doi.org/10.1002/..

5

A Study to Evaluate Relative Bioavailability, Food Effect, ..:

Stringer, Rowan ; Chen, Jin ; Shah, Bharti...
Clinical Pharmacology in Drug Development. 12 (2022) 2 - p. 122-131 , 2022

Link: https://doi.org/10.1002/..

6

Ligelizumab treatment for severe asthma: learnings from the..:

Trischler, Jordis ; Bottoli, Ivan ; Janocha, Reinhold...
Clinical & Translational Immunology. 10 (2021) 3 - p. , 2021

Link: https://doi.org/10.1002/..

7

Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug..:

Huth, Felix ; Schiller, Hilmar ; Jin, Yi...
Clinical and Translational Science. 15 (2021) 1 - p. 118-129 , 2021

Link: https://doi.org/10.1111/..

8

Comparison of pharmacokinetics, safety and tolerability of ..:

Bruin, Gerard ; Hockey, Hans‐Ulrich P. ; La Stella, Phillip...
British Journal of Clinical Pharmacology. 86 (2020) 2 - p. 338-351 , 2020

Link: https://doi.org/10.1111/..

9

P174 - Absorption, distribution, metabolism, and excretion ..:

Wang-Lakshman, Lydia ; Miao, Zhuang ; Gu, Jessie...
Drug Metabolism and Pharmacokinetics. 35 (2020) 1 - p. S76 , 2020

Link: https://doi.org/10.1016/..

10

Secukinumab Treatment Does Not Alter the Pharmacokinetics o..:

Bruin, Gerard ; Hasselberg, Anke ; Koroleva, Irina...
Clinical Pharmacology & Therapeutics. 106 (2019) 6 - p. 1380-1388 , 2019

Link: https://doi.org/10.1002/..

11

Fevipiprant has a low risk of influencing co-medication pha..:

Poller, Birk ; Woessner, Ralph ; Barve, Avantika...
Pulmonary Pharmacology & Therapeutics. 57 (2019) - p. 101809 , 2019

Link: https://doi.org/10.1016/..

12

CYP3A but not P‐gp plays a relevant role in the in vivo int..:

De Buck, Stefan ; Kucher, Klaus ; Hara, Hisanori..
Biopharmaceutics & Drug Disposition. 39 (2018) 8 - p. 394-402 , 2018

Link: https://doi.org/10.1002/..

13

Pharmacokinetics and safety of indacaterol and glycopyrroni..:

Ren, Shuang ; Sechaud, Romain ; Su, Zhenzhong...
Int. Journal of Clinical Pharmacology and Therapeutics. 55 (2017) 2 - p. 147-155 , 2017

Link: https://doi.org/10.5414/..

14

Pharmacokinetics of indacaterol and mometasone furoate deli..:

Vaidya, Soniya S. ; Khindri, Sanjeev ; Calder, Nicole...
Pulmonary Pharmacology & Therapeutics. 37 (2016) - p. 30-36 , 2016

Link: https://doi.org/10.1016/..

15

Intravenous Dosing as an Alternate Approach to Safely Achie..:

Ufer, Mike ; Sagkriotis, Alexandros ; Salunke, Atish...
Clinical Therapeutics. 38 (2016) 12 - p. 2589-2597 , 2016

Link: https://doi.org/10.1016/..